Autosomal Dominant Polycystic Kidney Disease (ADPKD) is not currently considered to be a risk factor for renal cell carcinoma (RCC). We present data from our institution demonstrating incidence of RCC with ADPKD above the incidence rate for RCC in the general population, as well as that in patients with end-stage renal disease (ESRD). The discussion relates our findings in the context of the current literature including recent case reports published in this entity.
Introduction
Since Walters and Brasch first described renal cell carcinoma occurring in ADPKD in 1934, 50 more cases have been reported in the literature [1, 2] . Most cases of RCC in ADPKD have been unilateral, however, 12 cases of bilateral RCC in this patient population have been reported since the first in 1954 by Borski and Kimbrough [2, 3] . While premalignant changes have been shown to occur in ADPKD, clinical research has not supported an association between RCC and ADPKD until Hajj et al. suggested an increased incidence of RCC in patients with ADPKD [4] [5] [6] . Current literature recognizes that RCC tends to occur at a younger age, and is more often bilateral in ADPKD patients, however, there is currently no recognized increased risk of RCC amongst ADPKD patients compared to the general population [7, 8] . This paper presents cases of RCC in ADPKD from our institution between 2000 and 2010.
Methods and Materials
All institutional cases of either unilateral or bilateral nephrectomy between 2000 and 2010, 177 cases in total, were reviewed for the pathologic diagnosis of ADPKD. Cases resulting from other causes of cystic disease such as acquired cystic disease, benign cysts, autosomal recessive polycystic kidney disease, tuberous sclerosis, and Von-Hippel Lindau disease were excluded. Six cases of ADPKD were identified in this patient cohort ( Table 1) . The presence of renal cell carcinoma was reviewed, yielding two patients who had both ADPKD and RCC, as well as one with renal papillary adenoma. Figure 1 shows pathologic specimens of ADPKD with RCC. utosomal dominant polycystic kidney disease was pe our review show that 2 of 6 patients with ented with overt RCC at time of nephrecal cell carcinoma is estimated to be 18.4 per 100 000 in men and 9.5 per 100 000 in women cell type with the remainder having chromophilic, chromophobic, oncocytic, or papillary [11] . Cigarette smokhave shown that RCC presents in ADPKD w He Receiv or transp or to nephrectom A Pubmed search combining renal cell carcinoma and a rformed which yielded 47 independent papers. These papers were reviewed and 50 case reports of RCC in ADPKD were identified, 12 with bilateral involvement.
Results
The data from ADPKD pres tomy, 1 with bilateral malignancies. In addition, subject 1 was found to have singular areas of papillary neoplasia identified in bilateral kidneys; each measuring 0.4 cm. Microscopic examination of this tissue revealed lowgrade papillary renal cell carcinoma. According to the current WHO classification system, the only histologic distinguishing factor between papillary renal cell carcinoma (PRCC) and papillary adenoma is size. Currently, the WHO classification system defines papillary adenomas as epithelial lesions with a tubulopapillary architecture measuring less than 5 mm [9] . Although the areas of neoplasia in the latter patient meet the specifications of adenoma according to the WHO classification system, we include this patient in our study due to bilateral kidney involvement and characteristic histology of papillary renal cell carcinoma despite a 1 mm size discrepancy between papillary adenoma and papillary renal cell carcinoma. Specimen from subject 3 demonstrated 2 separated areas of clear cell RCC in the left kidney (1.1 cm and 0.55 cm), and one clear cell RCC in the right kidney measuring 0.2 cm. Specimen from subject 6 demonstrated a 3.5 cm clear cell RCC in the right kidney.
Discussion
The incidence of ren [10] . Between 70% and 80% of patients with spontaneous renal cell carcinoma are diagnosed as having clear ing, obesity, chronic hemodialysis, and hypertension are considered risk factors for renal cell carcinoma [12, 13] . The incidence of ADPKD is 1 in 6000 [14] . The incidence of end-stage renal disease due to ADPKD is 8.7 per 1 000 000 men and 6.9 per 1 000 000 million women in the United States [11] . End stage renal disease in patients with ADPKD account for 10% -15% of dialysis patients [15] . Historically, neither epidemiologic nor clinical retrospective studies have established a link between RCC and ADPKD [4] . The association between RCC and ADPKD remains controversial, and there is scarce literature available attempting to establish a link between these disorders [6] . Current literature states that there is no increased risk of RCC in patients with ADPKD despite presentation at a younger age and increased incidence of bilateral renal involvement [8] . The preoperative diagnosis of RCC in end-stage renal disease patients with ADPKD is cumbersome and difficult. Imaging studies such as ultrasound and computed tomography often fail due to the cystic degenerative changes of the kidneys. On the other hand, end-stage renal disease of any etiology is considered to be a risk factor for developing RCC. This makes finding a correlation between RCC and ADPKD difficult as it is often impossible to determine if a patient developed the malignancy as a primary result of ADPKD or due to the elevated risk associated with chronic hemodialysis in end-stage renal disease [16] .
According to our literature search, 50 cases of RCC in ADPKD have been described in the literature, 12 of which were bilateral [2] . Table 2 lists 38 of these cases. These reports ith several unique characteristics: younger age at presentation, more likely to present with fever, and more likely to be bilateral, multicentric and sarcomatoid in type [5] . To date, there has been little evidence that the [6] . These findings along with an incidence of 50% in our patient population, even in a small study, indicate an increased risk of RCC in patients with ADPKD. Additionally, the propensity of these malignancies to present bilaterally and at a younger age compared to the general population also suggests an elevated risk in this patient population. This incidence of RCC is also far above that which is observed in ESRD patients with secondary acquired renal cystic disease (ARCD), a well documented risk factor for the development of RCC. The risk of developing ARCD increases with time spent on dialysis. For example, Ishikawa and coworkers found ARCD in 44% of patients who had been receiving hemodialysis for less than 3 years but in 79% of those who had been receiving hemodialysis for a longer time [19] . Overall, eighty percent of patients with end-stage renal failure eventually develop acquired renal cystic disease, and 1% to 2% of this subgroup develops RCC over 10 years of follow-up. If no RCC has developed after 10 years with ARCD, the risk is considered almost zero [7] . In contrast, at least two of the three ADPKD patients with RCC in our study had not been on hemodialysis for more than three years prior to the diagnosis of RCC, further suggesting a specific link between ADPKD and RCC in these patients.
Should this link be confirmed, then early bilateral nephrectomy in ADPKD patients with end-stage renal disease should be recommended.
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